Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study
BMJ Kempen et al. 339: b2480

Web Extra

Extra material supplied by the author

Files in this Data Supplement:

Data Supplement - Supplemental table 1: Systemic inflammatory diseases observed in the study cohort
Data Supplement - Supplemental table 2: Risk of mortality and cancer mortality vis-�-vis the 1999-2005 United States general population, standardized for age, race, and sex, by site of ocular inflammation and immunosuppressive treatment received
Data Supplement - Supplemental table 3: Use of immunosuppressive therapy and the risk of overall mortality (excluding patients with systemic inflammatory diseases)
Data Supplement - Supplemental table 4: Use of immunosuppressive therapy and the risk of mortality caused by cancer (excluding patients with systemic inflammatory diseases)